AMRI promotes Richard A. Saffee to Vice President and General Manager of Large Scale Manufacturing
AMRI announced that Richard A. Saffee has been promoted to the newly created role of Vice President and General Manager of Large Scale Manufacturing, effective immediately. He will continue to report to Steven R. Hagen, Ph.D., Senior Vice President of Pharmaceutical Development and Manufacturing.
Mr. Saffee will assume oversight for large scale manufacturing in Aurangabad, India in addition to his current responsibilities for leadership of AMRI's large scale manufacturing and GMP business in the United States in the Capital Region of New York. Additionally, Mr. Saffee will work with AMRI's Holywell, UK site to assist them in their large scale manufacturing business.
Before coming to AMRI, Mr. Saffee led manufacturing activities for multiple U.S.-based operations for Pfizer Global Manufacturing. and Pfizer Global Human Health. Prior to the acquisition of Parke-Davis by Pfizer, Mr. Saffee held roles of increasing responsibility at Parke-Davis including Director of Chemical Manufacturing and Area Production Manager.
Mr. Saffee earned a Master's degree in Business Administration from Grand Valley State University in Allendale, Michigan and a Bachelor's of Science degree in Chemical Engineering from the University of Michigan in Ann Arbor, Michigan.
Most read news
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Cells defend themselves from viruses, bacteria with armor of protein errors
Alnylam and Medtronic Advance Collaboration on Drug-Device Combinations with RNAi Therapeutics for CNS Diseases - Collaboration Focuses on RNAi Therapeutic Program for Huntington's Disease
MagForce AG Announces Treatment of Recurrent Glioblastoma Patient with NanoTherm Therapy
Cell Genesys San Diego Manufacturing Operation Acquired by Genzyme
Galapagos announces new collaboration agreements and a management appointment

Novozymes Biopharma Invests in New cGMP Facility for Production of Bacillus-based Hyaluronic Acid
New EIP: Support for bioeconomy key to productive and sustainable agriculture
Cornell researcher works to develop cheap, quick health test for people with HIV/AIDS in developing countries
